Time for $5 graphics

Cepheid's price gouging for lifesaving test

Cepheid, it's time for $5

Tuberculosis - The world's deadliest infectious disease

Danaher! Cepheid! Don't fail this test! Drop the Price! $5 for ALL GeneXpert tests

Read, watch, share

Medical staff providing treatment in MSF-supported Bolomba Ebola treatment center, Equateur province, DRC, August 2020

Photo credit: Franck Ngonga/MSF

Ebola: the diagnostic blind spot

Newsletter cover image

Newsletter |

12 July 2026

Test: have you heard about tests?

Report Cover Image

07 July 2026

MSF proposal for Kenya’s Social Health Authority (SHA) benefits package to include analogue insulin pens to improve care for people living with diabetes

A close-up of Siwar holding her insulin pen. Siwar has type 1 diabetes and received her insulin pen from the MSF clinic in Arsal. Drawing on Siwar's experience, her father explains to how insulin pens make life easier for diabetic kids.

Photo Credit: Carmen Yahchouchi/MSF

Press release |

07 July 2026

Diabetes

MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package

4 min

WHO Executive Board's Special Session on Ebola

UN Photo/Christopher Black

Statement |

06 July 2026

Pandemic preparedness

MSF statement at IGWG7

2 min

Report Cover Image

Technical brief |

24 June 2026

Diagnostics Research and development

The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions

Statement

Statement |

16 June 2026

Research and development

European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access

Ministry of Health laboratory technician Allieu Tucker conducts a subculture test on patients’ samples in the laboratory of the MSF-supported Government Maternity and Children’s Hospital in Hangha, Kenema District, Sierra Leone.

Press release |

16 June 2026

Research and development

Europe

Public investment demands public benefits: European Biotech Act must deliver for people

2 min